HCM
ABBV icon

Highline Capital Management’s AbbVie ABBV Stock Holding History

Highline Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,293,600
Closed -$68.3M – 29
2013
Q4 		$68.3M Buy
1,293,600
+3,200
+0.2% +$157K 4.15% 14
2013
Q3 		$57.7M Buy
1,290,400
+1,261,400
+4,350% +$55.9M 3.88% 15
2013
Q2 		$1.2M Buy
+29,000
New +$1.27M 0.1% 29

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Highline Capital Management's ABBV Position: Q4 2015 in Review

Highline Capital Management sold out of AbbVie (ABBV) in Q4 2015, closing a stake of 2,258,900 shares — an estimated $123M sold.

Highline Capital Management first reported a position in ABBV in Q2 2013 and held it in 9 quarters. The position peaked at $160M in Q4 2014. 1,635 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

  • Highline Capital Management reported no remaining AbbVie position as of Q4 2015 after selling out during the quarter.
  • Highline Capital Management sold 2,258,900 AbbVie shares in Q4 2015, an estimated $123M.
  • Highline Capital Management first reported a position in AbbVie in Q2 2013 and held it in 9 quarters.
  • Highline Capital Management's AbbVie position peaked at $160M in Q4 2014.
  • 1,635 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Highline Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.